TriMas vs XPEL
TRS and XPEL side by side, both in fabricated metal products, except machinery and transportation equipment. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How TRS and XPEL compare
TriMas is the larger company, worth 1.3 times as much as XPEL ($1.3B against $1.0B).
On earnings, TriMas is cheaper: it trades at 1.5× trailing earnings, against 18.7× for XPEL.
XPEL grew revenue faster over the last twelve months (13.2% versus 5.0% for TriMas).
TriMas keeps more of each dollar of sales as profit, with a net margin of 136% compared with 10.8% at XPEL.
TriMas pays a dividend yielding 0.44%; XPEL does not pay one.
XPEL scores higher on the StockData Score (17 against 15 for TriMas), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | TRS | XPEL |
|---|---|---|
| Size and price | ||
| Market cap | $1.3B | $1.0B |
| Share price | $36.45 | $36.83 |
| Change, 1 year | 17.3% | −9.6% |
| Change, 5 years | 3.5% | −48.9% |
| Beta (5Y) | 0.63 | 1.10 |
| Employees | 3,700 | 1,337 |
| StockData Score | ||
| Total score | 15 | 17 (better) |
| Valuation score | 3 | 4 (better) |
| Growth score | 3 | 3 |
| Performance score | 3 | 5 (better) |
| Health score | 3 | 5 (better) |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 1.5× (better) | 18.7× |
| P/S | 2.0× (better) | 2.0× |
| P/B | 0.9× (better) | 3.3× |
| EV/EBITDA | 45.6× | 15.1× (better) |
| PEG | 0.06 (better) | 2.58 |
| FCF yield | −0.76% | −0.28% (better) |
| Fair value | $23.68 | $41.65 |
| Margin of safety | −54.0% | 11.6% (better) |
| Growth | ||
| Revenue growth (TTM) | 5.0% | 13.2% (better) |
| Revenue growth, 5Y average | −3.5% | 24.5% (better) |
| Net income growth (TTM) | 2326% (better) | 12.5% |
| EPS growth (TTM) | 2541% (better) | 11.9% |
| EPS growth, 5Y average | – | 22.9% |
| Profitability | ||
| Gross margin | 21.0% | 42.9% (better) |
| Operating margin | 1.5% | 13.5% (better) |
| Net margin | 136% (better) | 10.8% |
| FCF margin | −1.5% | −0.57% (better) |
| Return on equity | 83.9% (better) | 19.5% |
| Return on invested capital | 1.2% | 21.3% (better) |
| Financial health | ||
| Debt / equity | 0.28 | 0.15 (better) |
| Net debt / EBITDA | −83.39 | 0.06 (better) |
| Interest coverage | 0.6× | 256× (better) |
| Current ratio | 5.44 (better) | 2.61 |
| Altman Z-score | 2.53 | 6.73 (better) |
| Piotroski F-score | 5 | 5 |
| Dividends and buybacks | ||
| Dividend yield | 0.44% | – |
| Payout ratio | 0.69% | – |
| Years of dividend growth | 0 | – |
| Buyback yield | 13.3% | – |
| Shareholder yield | 13.8% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 83.7% | 85.0% |
| Held by insiders | 19.6% | 4.4% |
| Insider net buying, 12 months | −$872K | – |
| Short interest, % of float | 12.1% | 10.2% |
Go deeper
- TRS stock overview
- TRS income statement
- TRS valuation and score
- XPEL stock overview
- XPEL income statement
- XPEL valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.